table of content
1 Introduction to Research & Analysis Reports
1.1 mRNA Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Therapy Overall Market Size
2.1 Global mRNA Therapy Market Size: 2022 VS 2029
2.2 Global mRNA Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top mRNA Therapy Players in Global Market
3.2 Top Global mRNA Therapy Companies Ranked by Revenue
3.3 Global mRNA Therapy Revenue by Companies
3.4 Top 3 and Top 5 mRNA Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies mRNA Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 mRNA Therapy Players in Global Market
3.6.1 List of Global Tier 1 mRNA Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 mRNA Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global mRNA Therapy Market Size Markets, 2022 & 2029
4.1.2 Vaccine
4.1.3 Drugs
4.2 By Type - Global mRNA Therapy Revenue & Forecasts
4.2.1 By Type - Global mRNA Therapy Revenue, 2018-2023
4.2.2 By Type - Global mRNA Therapy Revenue, 2024-2029
4.2.3 By Type - Global mRNA Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global mRNA Therapy Market Size, 2022 & 2029
5.1.2 mRNA Targeted Delivery in vivo
5.1.3 Genetically Modified T cells
5.1.4 Transforming Nanoparticles to Develop Immunotherapy for Cancer
5.1.5 Small Molecule Drugs Discovery
5.2 By Application - Global mRNA Therapy Revenue & Forecasts
5.2.1 By Application - Global mRNA Therapy Revenue, 2018-2023
5.2.2 By Application - Global mRNA Therapy Revenue, 2024-2029
5.2.3 By Application - Global mRNA Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global mRNA Therapy Market Size, 2022 & 2029
6.2 By Region - Global mRNA Therapy Revenue & Forecasts
6.2.1 By Region - Global mRNA Therapy Revenue, 2018-2023
6.2.2 By Region - Global mRNA Therapy Revenue, 2024-2029
6.2.3 By Region - Global mRNA Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America mRNA Therapy Revenue, 2018-2029
6.3.2 US mRNA Therapy Market Size, 2018-2029
6.3.3 Canada mRNA Therapy Market Size, 2018-2029
6.3.4 Mexico mRNA Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe mRNA Therapy Revenue, 2018-2029
6.4.2 Germany mRNA Therapy Market Size, 2018-2029
6.4.3 France mRNA Therapy Market Size, 2018-2029
6.4.4 U.K. mRNA Therapy Market Size, 2018-2029
6.4.5 Italy mRNA Therapy Market Size, 2018-2029
6.4.6 Russia mRNA Therapy Market Size, 2018-2029
6.4.7 Nordic Countries mRNA Therapy Market Size, 2018-2029
6.4.8 Benelux mRNA Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia mRNA Therapy Revenue, 2018-2029
6.5.2 China mRNA Therapy Market Size, 2018-2029
6.5.3 Japan mRNA Therapy Market Size, 2018-2029
6.5.4 South Korea mRNA Therapy Market Size, 2018-2029
6.5.5 Southeast Asia mRNA Therapy Market Size, 2018-2029
6.5.6 India mRNA Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America mRNA Therapy Revenue, 2018-2029
6.6.2 Brazil mRNA Therapy Market Size, 2018-2029
6.6.3 Argentina mRNA Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa mRNA Therapy Revenue, 2018-2029
6.7.2 Turkey mRNA Therapy Market Size, 2018-2029
6.7.3 Israel mRNA Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia mRNA Therapy Market Size, 2018-2029
6.7.5 UAE mRNA Therapy Market Size, 2018-2029
7 mRNA Therapy Companies Profiles
7.1 Moderna
7.1.1 Moderna Company Summary
7.1.2 Moderna Business Overview
7.1.3 Moderna mRNA Therapy Major Product Offerings
7.1.4 Moderna mRNA Therapy Revenue in Global Market (2018-2023)
7.1.5 Moderna Key News & Latest Developments
7.2 BioNTech
7.2.1 BioNTech Company Summary
7.2.2 BioNTech Business Overview
7.2.3 BioNTech mRNA Therapy Major Product Offerings
7.2.4 BioNTech mRNA Therapy Revenue in Global Market (2018-2023)
7.2.5 BioNTech Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer mRNA Therapy Major Product Offerings
7.3.4 Pfizer mRNA Therapy Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Arcturus Therapeutics Holdings Inc.
7.4.1 Arcturus Therapeutics Holdings Inc. Company Summary
7.4.2 Arcturus Therapeutics Holdings Inc. Business Overview
7.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Major Product Offerings
7.4.4 Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue in Global Market (2018-2023)
7.4.5 Arcturus Therapeutics Holdings Inc. Key News & Latest Developments
7.5 Astrazeneca
7.5.1 Astrazeneca Company Summary
7.5.2 Astrazeneca Business Overview
7.5.3 Astrazeneca mRNA Therapy Major Product Offerings
7.5.4 Astrazeneca mRNA Therapy Revenue in Global Market (2018-2023)
7.5.5 Astrazeneca Key News & Latest Developments
7.6 CureVac
7.6.1 CureVac Company Summary
7.6.2 CureVac Business Overview
7.6.3 CureVac mRNA Therapy Major Product Offerings
7.6.4 CureVac mRNA Therapy Revenue in Global Market (2018-2023)
7.6.5 CureVac Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
